Searchable abstracts of presentations at key conferences in endocrinology

ea0011p174 | Clinical case reports | ECE2006

An unusual carcinoid tumor in a case of Cushing syndrome

Turki ZT , Aouididi FA , Smida HS , Ben Salem LBS , Bouguerra RB , Ben Slama CBS

The overall incidence of carcinoid tumors has been estimated to be 1 to 2 cases /100000 people in USA. Carcinoid tumors habitually accounts for 1% of all cases of Cushing’s syndrome. The authors report an unusual case of ectopic secretion of corticotropin from pulmonary carcinoid tumor.A. F. is a 29 years old patient who has been referred for hypercorticism with patent features including trophical signs and severe depression.L...

ea0008oc4 | Growth and Development | SFE2004

IGF-independent acceleration of myogenesis by IGFBP-5: modulation of cell survival and differentiation signalling pathways

Cobb LJ , Gonzalez I , Tripathi G , Lovett FA , Salih DAM , Godwin KS , Pell JM

The insulin-like growth factor binding proteins (IGFBPs-1 to -6) complex IGF-I and -II and were originally assumed to limit IGF access to the main IGF signalling receptor (IGFR) and decrease IGF activity. IGFBP-5 is the most conserved of the IGFBPs. Examination of its primary sequence reveals that, in addition to the key IGF binding domain, additional functional motifs are present that are not related to its IGF binding function.IGFBP-5 is upregulated du...

ea0008go4 | (1) | SFE2004

IGF-independent acceleration of myogenesis by IGFBP-5: modulation of cell survival and differentiation signalling pathways

Cobb LJ , Gonzalez I , Tripathi G , Lovett FA , Salih DAM , Godwin KS , Pell JM

The insulin-like growth factor binding proteins (IGFBPs-1 to -6) complex IGF-I and -II and were originally assumed to limit IGF access to the main IGF signalling receptor (IGFR) and decrease IGF activity. IGFBP-5 is the most conserved of the IGFBPs. Examination of its primary sequence reveals that, in addition to the key IGF binding domain, additional functional motifs are present that are not related to its IGF binding function.IGFBP-5 is upregulated du...

ea0073ep220 | Thyroid | ECE2021

Thyrotoxic periodic paralysis presenting in an adult male from Cambodia: a case report

Faïza Bensmaine , Gaelle Barrande , Paul Desaint , Alexis Jardin , Gaetan Plantefeve , Pierre Jean Guillausseau

IntroductionThyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism characterized by the sudden onset of hypokalemia and muscle paralysis. This rare but possible clinical presentation of thyrotoxicosis is significantly more predominant in males of asian descent. The mechanisms of hypokalemia are incompletely understood. The prevailing theories include increased Na-K ATPase pump activity and mutations in genes encoding Kir channels i...

ea0042il8 | Androgen Receptor and Chromatin | Androgens2016

The Androgen Receptor chromatin landscape in prostate tumors: biomarker discovery and beyond

Stelloo Suzan , Nevedomskaya Ekaterina , Schuurman Karianne , Wessels Lodewyk FA , Henrique Rui , Jeronimo Carmen , Bergman Andries M , Zwart Wilbert

The androgen receptor (AR) plays a pivotal role in prostate cancer development, progression and hormone-therapy resistant disease. AR requires a permissive epigenetic state at distinct chromatin regions to facilitate gene expression programs. The vast majority of AR sites are found at active enhancer regions, hallmarked by histone modification H3K27Ac and devoid of repressive markers including H3K27me3. In search for novel biomarkers for prostate cancer prognostication, we per...

ea0090oc5.6 | Oral Communications 5: Adrenal and Cardiovascular Endocrinology 1 | ECE2023

Venous thromboembolism complications in Cushing’s syndrome: results of a secondary survey within the European Registries for Rare Endocrine Conditions (EuRRECa) and the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

Cherenko Mariya , Appelman-Dijkstra Natasha , Priego Zurita Ana Luisa , Klok F.A. , Biermasz Nienke , M. Dekkers Olaf , Ahmed Faisal , Pereira Alberto M.

Background: Venous thromboembolism(VTE) is a well-known perioperative complication in patients with Cushing’s syndrome(CS) and may be preventable. A recent report highlighted that thromboprophylaxis management in patients with CS still varies considerably across Endo-ERN reference centers but the actual incidence of VTE and its management in individual patients is unclear.Aim: To collect epidemiological and clinical data of new cases of CS reported ...